Home/ Supplements/ Electrolytes/ Cellular Forte Max3

Cellular Forte Max3

product on market Capsule Integrative Therapeutics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 43% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines essential minerals like calcium, magnesium, and phosphorus with IP-6 and inositol. Research provides strong evidence for the roles of these minerals in bone health and cellular function. However, overall evidence coverage for this specific ingredient combination remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Cellular Forte Max3
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
43%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
130 mg (13% DV)
190 mg (19% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:3)
40 mg (10% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
IP-6
800 mg
220 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Maitake (Grifola frondosa) Mushroom mycelium extract
30 mg
Market median: 450.0mg (130 products) 1 studies — no high-quality reviews

Other Ingredients

Vegetable Capsule Cellulose Stearic Acid Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendation: Take 2 capsules twice daily for maintenance, or as recommended by your healthcare professional. Best taken on an empty stomach. For maximum support, up to 10 capsules may be taken per day.

Warnings & Precautions

Do not use if pregnant, nursing or attempting to become pregnant. If taking any prescription drugs, consult your healthcare professional prior to use.

Formulation Notes

Contains no sugar, salt, wheat, yeast, gluten, soy, dairy products, artificial colors, flavors, preservatives or ingredients of animal origin.

Additional Information

LZ75812.C02 BLK581C

Immune Support

Metadata

Product Details

UPC / SKU8 71791 00096 4
DSLD Entry Date2017-09-21
Product TypeOther Combinations
FormCapsule
DSLD ID77059
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.